Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage.

IF 3.4 3区 医学 Q2 ONCOLOGY Cancer Epidemiology Biomarkers & Prevention Pub Date : 2025-02-06 DOI:10.1158/1055-9965.EPI-24-1247
Xiaosong Huang, Paul C Lott, Donglei Hu, Valentina A Zavala, Zoeb N Jamal, Tatiana Vidaurre, Sandro Casavilca-Zambrano, Jeannie Navarro Vásquez, Carlos A Castañeda, Guillermo Valencia, Zaida Morante, Mónica Calderón, Julio E Abugattas, Hugo A Fuentes, Ruddy Liendo-Picoaga, Jose M Cotrina, Silvia P Neciosup, Patricia Rioja Viera, Luis A Salinas, Marco Galvez-Nino, Scott Huntsman, Sixto E Sanchez, Michelle A Williams, Bizu Gelaye, Ana P Estrada-Florez, Guadalupe Polanco-Echeverry, Magdalena Echeverry, Alejandro Velez, Jenny A Carmona-Valencia, Mabel E Bohorquez-Lozano, Javier Torres, Miguel Cruz, Weang-Kee Ho, Soo Hwang Teo, Mei Chee Tai, Esther M John, Christopher A Haiman, David V Conti, Fei Chen, Gabriela Torres-Mejía, Lawrence H Kushi, Susan L Neuhausen, Elad Ziv, Luis G Carvajal-Carmona, Laura Fejerman
{"title":"Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage.","authors":"Xiaosong Huang, Paul C Lott, Donglei Hu, Valentina A Zavala, Zoeb N Jamal, Tatiana Vidaurre, Sandro Casavilca-Zambrano, Jeannie Navarro Vásquez, Carlos A Castañeda, Guillermo Valencia, Zaida Morante, Mónica Calderón, Julio E Abugattas, Hugo A Fuentes, Ruddy Liendo-Picoaga, Jose M Cotrina, Silvia P Neciosup, Patricia Rioja Viera, Luis A Salinas, Marco Galvez-Nino, Scott Huntsman, Sixto E Sanchez, Michelle A Williams, Bizu Gelaye, Ana P Estrada-Florez, Guadalupe Polanco-Echeverry, Magdalena Echeverry, Alejandro Velez, Jenny A Carmona-Valencia, Mabel E Bohorquez-Lozano, Javier Torres, Miguel Cruz, Weang-Kee Ho, Soo Hwang Teo, Mei Chee Tai, Esther M John, Christopher A Haiman, David V Conti, Fei Chen, Gabriela Torres-Mejía, Lawrence H Kushi, Susan L Neuhausen, Elad Ziv, Luis G Carvajal-Carmona, Laura Fejerman","doi":"10.1158/1055-9965.EPI-24-1247","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>A substantial portion of the genetic predisposition for breast cancer is explained by multiple common genetic variants of relatively small effect. A subset of these variants, which have been identified mostly in individuals of European (EUR) and Asian ancestries, have been combined to construct a polygenic risk score (PRS) to predict breast cancer risk, but the prediction accuracy of existing PRSs in Hispanic/Latinx individuals (H/L) remain relatively low. We assessed the performance of several existing PRS panels with and without addition of H/L-specific variants among self-reported H/L women.</p><p><strong>Methods: </strong>PRS performance was evaluated using multivariable logistic regression and the area under the ROC curve.</p><p><strong>Results: </strong>Both EUR and Asian PRSs performed worse in H/L samples compared with original reports. The best EUR PRS performed better than the best Asian PRS in pooled H/L samples. EUR PRSs had decreased performance with increasing Indigenous American (IA) ancestry, while Asian PRSs had increased performance with increasing IA ancestry. The addition of two H/L SNPs increased performance for all PRSs, most notably in the samples with high IA ancestry, and did not impact the performance of PRSs in individuals with lower IA ancestry.</p><p><strong>Conclusions: </strong>A single PRS that incorporates risk variants relevant to the multiple ancestral components of individuals from Latin America, instead of a set of ancestry-specific panels, could be used in clinical practice.</p><p><strong>Impact: </strong>The results highlight the importance of population-specific discovery and suggest a straightforward approach to integrate ancestry-specific variants into PRSs for clinical application.</p>","PeriodicalId":9458,"journal":{"name":"Cancer Epidemiology Biomarkers & Prevention","volume":" ","pages":"234-245"},"PeriodicalIF":3.4000,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11799839/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Epidemiology Biomarkers & Prevention","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1158/1055-9965.EPI-24-1247","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: A substantial portion of the genetic predisposition for breast cancer is explained by multiple common genetic variants of relatively small effect. A subset of these variants, which have been identified mostly in individuals of European (EUR) and Asian ancestries, have been combined to construct a polygenic risk score (PRS) to predict breast cancer risk, but the prediction accuracy of existing PRSs in Hispanic/Latinx individuals (H/L) remain relatively low. We assessed the performance of several existing PRS panels with and without addition of H/L-specific variants among self-reported H/L women.

Methods: PRS performance was evaluated using multivariable logistic regression and the area under the ROC curve.

Results: Both EUR and Asian PRSs performed worse in H/L samples compared with original reports. The best EUR PRS performed better than the best Asian PRS in pooled H/L samples. EUR PRSs had decreased performance with increasing Indigenous American (IA) ancestry, while Asian PRSs had increased performance with increasing IA ancestry. The addition of two H/L SNPs increased performance for all PRSs, most notably in the samples with high IA ancestry, and did not impact the performance of PRSs in individuals with lower IA ancestry.

Conclusions: A single PRS that incorporates risk variants relevant to the multiple ancestral components of individuals from Latin America, instead of a set of ancestry-specific panels, could be used in clinical practice.

Impact: The results highlight the importance of population-specific discovery and suggest a straightforward approach to integrate ancestry-specific variants into PRSs for clinical application.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
拉丁美洲血统妇女多重乳腺癌多基因风险评分面板的评估。
背景:乳腺癌的很大一部分遗传易感性是由多个影响相对较小的常见遗传变异来解释的。这些变异的一个子集,主要是在欧洲和亚洲血统的个体中发现的,已经被结合起来构建了一个多基因风险评分(PRS)来预测乳腺癌的风险,但是现有的PRS在西班牙裔/拉丁裔个体(H/L)中的预测准确性仍然相对较低。我们在自我报告的H/L女性中评估了几个现有的有或没有添加H/L特异性变异的PRS面板的性能。方法:采用多变量logistic回归和受试者工作特征曲线下面积(AUC)评价其疗效。结果:与原始报告相比,欧洲和亚洲的PRSs在H/L样本中表现更差。在混合H/L样品中,最佳欧洲PRS性能优于最佳亚洲PRS。欧洲PRSs的性能随美洲原住民血统的增加而下降,而亚洲PRSs的性能随美洲原住民血统的增加而增加。添加2 H/L snp提高了所有prs的性能,特别是在具有高IA血统的样本中,并且不影响具有低IA血统的个体的prs的性能。结论:单一的PRS纳入了与拉丁美洲个体的多个祖先成分相关的风险变异,而不是一组特定的祖先面板,可以用于临床实践。影响:结果强调了人群特异性发现的重要性,并提出了一种直接的方法,将祖先特异性变异整合到PRS中用于临床应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cancer Epidemiology Biomarkers & Prevention
Cancer Epidemiology Biomarkers & Prevention 医学-公共卫生、环境卫生与职业卫生
CiteScore
6.50
自引率
2.60%
发文量
538
审稿时长
1.6 months
期刊介绍: Cancer Epidemiology, Biomarkers & Prevention publishes original peer-reviewed, population-based research on cancer etiology, prevention, surveillance, and survivorship. The following topics are of special interest: descriptive, analytical, and molecular epidemiology; biomarkers including assay development, validation, and application; chemoprevention and other types of prevention research in the context of descriptive and observational studies; the role of behavioral factors in cancer etiology and prevention; survivorship studies; risk factors; implementation science and cancer care delivery; and the science of cancer health disparities. Besides welcoming manuscripts that address individual subjects in any of the relevant disciplines, CEBP editors encourage the submission of manuscripts with a transdisciplinary approach.
期刊最新文献
Urinary Levels of Endocrine-Disrupting Chemicals and Breast Density in Young Women. Evaluating Efficacy of Cervical HPV-HR DNA Testing as Alternative to PET/CT Imaging for Posttreatment Cancer Surveillance: Retrospective Proof-of-Concept Study. Food Insecurity and Clinical Biomarkers of Inflammation among Cancer Survivors in the All of Us Research Program. Highly Sensitive DNA Testing of Fusobacterium nucleatum in Colorectal Tumors. Rurality of Residence and Distance to Clinic Are Risk Factors for Non-engagement in Childhood Cancer Survivor Care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1